UK TRIAL FOR A POTENTIAL NEW PSORIASIS MEDICINE

Novartis Pharmaceuticals UK Ltd is currently conducting a phase 3b clinical trial investigating a potential new medicine for the treatment of moderate to severe psoriasis.

This website aims to help you decide whether you would like to find out more about participating in the trial.

WE ARE LOOKING FOR PEOPLE WHO

- A UK resident
- Over the age of 18
- Have moderate-severe psoriasis
- Have received treatment for psoriasis from a dermatologist

Please note that meeting the above criteria does not guarantee suitability for the trial.